Innovation and market dynamics in the EPO market
Enrico Sorisio and
Additional contact information
Enrico Sorisio: PharmaNess scarl; University of Turin, Postal: Italy
No 2006:3, HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme
In this paper we study the demand and supply of erythropoietin in four Nordic countries, using an econometric model based on discrete choice and a random utility model. It measures the effect of price changes as well as the loyalty of patients and physicians to a drug. Our main aims are to estimate demand for EPO and to determine the degree of competition in this Nordic market. The main motivation for this paper is to analyze the impact of product innovation on market power and welfare, e.g. on consumer and producer surplus. The product innovation is the entry of Aranesp in the Nordic market.
Keywords: Discrete choice; demand for pharmaceuticals; monopolistic competition; EPO (search for similar items in EconPapers)
JEL-codes: C35 D43 I18 L11 (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-com, nep-cse, nep-dcm, nep-hea, nep-knm, nep-mic and nep-tid
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
Working Paper: Innovation and market dynamics in the EPO market (2006)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:hhs:oslohe:2006_003
Access Statistics for this paper
More papers in HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme HERO / Department of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway. Contact information at EDIRC.
Bibliographic data for series maintained by Kristi Brinkmann Lenander ().